Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Dose Cyclophosphamide for the Treatment of Severe Autoimmune Enteropathy

NCT00258180 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00258180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00258180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Dose Cyclophosphamide for the Treatment of Severe Autoimmune Enteropathy
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
August 15, 2005
Completion date
February 24, 2009
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea, gastrointestinal complications, unspecified childhood solid tumor, protocol specific